News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
AstraZeneca PLC Settles Seroquel Case; Agrees to Pay $520 Million to Settle Investigation
April 27, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Drug maker AstraZeneca has agreed to pay $520 million to settle a federal investigation into its marketing practices for the antipsychotic drug Seroquel, the New York Times reported on its website on Monday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Government
After Speaking out of Turn, Malone Steps Down From Vaccine Committee
March 27, 2026
·
2 min read
·
Tristan Manalac
Government
HHS Denies Disbandment of CDC Vaccine Advisory Group in Wake of Court Ruling
March 20, 2026
·
2 min read
·
Tristan Manalac
Policy
FDA Policy Tracker 2026: RMAT Awards for Assets on Hold, Animal Testing Alternatives
March 19, 2026
·
9 min read
·
BioSpace Editorial Staff
Legal
Kennedy’s Vaccine Policy Overhaul Stymied by Federal Judge
March 17, 2026
·
3 min read
·
Tristan Manalac